Vascular Endothelial Growth Factors

A family of angiogenic proteins that are closely-related to VASCULAR ENDOTHELIAL GROWTH FACTOR A. They play an important role in the growth and differentiation of vascular as well as lymphatic endothelial cells.
Also Known As:
Networked: 326 relevant articles (8 outcomes, 32 trials/studies)

Relationship Network

Bio-Agent Context: Research Results


1. Bremnes, Roy M: 4 articles (11/2015 - 02/2009)
2. Busund, Lill-Tove: 4 articles (11/2015 - 02/2009)
3. Alitalo, Kari: 4 articles (08/2013 - 09/2002)
4. Ylä-Herttuala, Seppo: 4 articles (12/2012 - 05/2006)
5. Al-Saad, Samer: 3 articles (11/2015 - 02/2009)
6. Anisimov, Andrey: 3 articles (08/2013 - 12/2010)
7. Shibuya, Masabumi: 3 articles (01/2013 - 03/2008)
8. Donnem, Tom: 3 articles (03/2011 - 02/2009)
9. Andersen, Sigve: 2 articles (11/2015 - 03/2011)
10. Smith, Jonathan M: 2 articles (01/2015 - 01/2011)

Related Diseases

1. Macular Edema
2. Retinal Vein Occlusion
01/01/2012 - "The objective of this review is to evaluate the evidence and discuss the rationale behind the recent suggestions that intravitreal pharmacotherapy by corticosteroids and anti-vascular endothelial growth factors may be useful in the treatment of retinal vein occlusion."
01/01/2015 - "Safety and efficacy of dexamethasone intravitreal implant (Ozurdex) for the treatment of persistent macular edema secondary to retinal vein occlusion in eyes previously treated with anti-vascular endothelial growth factors."
04/01/2014 - "Intravitreal corticosteroids and intravitreal anti-vascular endothelial growth factors are modalities of treatment for macular edema secondary to branch retinal vein occlusion (BRVO). "
01/01/2013 - "For this review, a search of PubMed from January 1989 to May 2013 was performed using the following terms (or combination of terms): vascular endothelial growth factors, VEGF, age-related macular degeneration, VEGF-Trap eye in wet AMD, VEGF-Trap eye in diabetic retinopathy, VEGF-Trap eye in retinal vein occlusions, aflibercept. "
03/01/2014 - "There are several treatment modalities for branch retinal vein occlusion and specifically for its complications, such as macular edema, vitreous hemorrhage, retinal neovascularization, and retinal detachment, including anti-aggregative therapy and fibrinolysis, isovolemic hemodilution, vitrectomy with or without sheathotomy, peripheral scatter and macular grid retinal laser therapy, non-steroid agents, intravitreal steroids, and intravitreal anti-vascular endothelial growth factors (anti-VEGFs)."
3. Stomach Neoplasms (Stomach Cancer)
4. Colorectal Neoplasms (Colorectal Cancer)
5. Breast Neoplasms (Breast Cancer)

Related Drugs and Biologics

1. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
2. Vascular Endothelial Growth Factors
3. Adrenal Cortex Hormones (Corticosteroids)
4. Intercellular Signaling Peptides and Proteins (Growth Factors)
5. bevacizumab
6. Epidermal Growth Factor (EGF)
7. Platinum
8. panitumumab (Vectibix)
9. cetuximab (Erbitux)
10. Nuclear Proteins (Protein, Nuclear)

Related Therapies and Procedures

1. Intravitreal Injections
2. Lasers (Laser)
3. Light Coagulation
4. Drug Therapy (Chemotherapy)
5. Vitrectomy